Isoprenaline (Isoproterenol) Infusion
Syringe pump continuous infusion preparation (20 mcg/mL), chronotropic titration, and arrhythmia surveillance protocol.
Syringe Pump Infusion Preparation (Standard Concentration)
| Ampoule Presentation | 5 mL ampoule (0.2 mg/mL = 200 mcg/mL of isoprenaline hydrochloride) |
|---|---|
| Isoprenaline Dose | 1 mg (5 mL = one 5 mL ampoule) |
| Compatible Diluent | 45 mL of 5% Dextrose (D5W) |
| Final Syringe Volume | 50 mL |
| Final Concentration | 20 mcg/mL |
| Stability | 24 hours at room temperature, protected from light |
Materials Required
- Isoprenaline ampoule 0.2 mg/mL (5 mL) × 1
- 60 mL Luer-lock syringe
- 5% Dextrose (D5W)
- Sterile drawing-up needle / filter needle
- Dedicated syringe pump infusion label
- Extension line (100 cm), light-protective if available
- Alcohol chlorhexidine swabs
Preparation Procedure (Aseptic Non-Touch Technique)
- Verification: Verify the written physician order, patient identity, clinical indication, baseline heart rate, rhythm, and QT interval.
- Hand Hygiene: Perform thorough hand hygiene and clean preparation workspace.
- Ampoule Check: Check the isoprenaline ampoule for:
- Correct drug and strength (mg/mL), isoprenaline hydrochloride
- Expiry date
- Container integrity, clarity, and absence of precipitate or discoloration
- Withdrawal: Withdraw 5 mL from one 0.2 mg/mL ampoule into a 60 mL Luer-lock syringe (Total isoprenaline drawn: 5 mL = 1 mg isoprenaline).
- Dilution: Add 45 mL of 5% Dextrose to a final volume of 50 mL.
- Mixing: Gently invert the syringe several times to ensure uniform mixing.
- Visual Inspection: Inspect solution to ensure it is clear, colorless, and free of visible particles. A pink or brown tint indicates oxidation; discard the syringe.
- Labeling & Dual Verification: Apply infusion label and obtain an independent double-check by another registered nurse.
- Syringe Pump Setup: Prime the extension set, install into the syringe pump, and protect from light.
🔒 Lumen Policy: Isoprenaline is inactivated in alkaline solutions (sodium bicarbonate). Infuse via a dedicated lumen so flushes of other drugs do not deliver an unintended bolus.
⚠️ Line Access: Isoprenaline may be infused via a peripheral or central line. It is a bridge therapy: arrange temporary or permanent pacing early when bradycardia is caused by heart block.
Receptor & Hemodynamic Profile
Isoprenaline is a pure, non-selective β-agonist with virtually no α-activity. Heart rate and contractility rise, while systemic vascular resistance falls.
β1 Stimulation (Cardiac)
- Increases sinus rate, escape rhythms, and AV nodal conduction
- Increases contractility and cardiac output
β2 Stimulation (Vascular)
- Peripheral vasodilation; mean arterial pressure may fall
- Bronchodilation
Net Myocardial Effect
- Tachycardia with lower diastolic (coronary perfusion) pressure
- High risk of ischemia in coronary artery disease
Administration & Titration
Recommended Dosing Parameters
- Dosing Unit: Usually dosed in mcg/min (weight-based equivalent 0.01 to 0.1 mcg/kg/min).
- Administration Route: Administer via syringe pump; dedicated lumen preferred.
- Recommended Starting Dose: 0.5 to 1 mcg/min.
- Titration Step: Increase by 0.5 to 1 mcg/min every 3 to 5 minutes to the prescribed heart rate target.
- Typical Range: 0.5 to 5 mcg/min.
- Higher Doses: Up to 10 mcg/min only under direct intensivist or cardiology supervision.
- Heart Rate Target: The lowest rate that restores adequate perfusion, as prescribed (for example 60–80 bpm, or higher for torsades suppression).
- Syringe Continuity: Do not allow the infusion to run out. A syringe can be made up to a maximum of 1 hour in advance and labelled clearly with contents and expiry.
- Discard Policy: Discard 24 hours after preparation or earlier if the solution becomes discoloured, cloudy, or contaminated.
Hemodynamic Monitoring Requirements
- Continuous ECG monitoring with transcutaneous pacing pads applied and pacing equipment at the bedside.
- Monitor heart rate continuously and blood pressure every 5 minutes during titration (arterial line preferred).
- Watch for ventricular ectopy, ventricular tachycardia, and atrial tachyarrhythmias.
- Observe for chest pain or ECG changes suggesting myocardial ischemia.
- Check serum potassium and magnesium; β-agonism lowers potassium and hypokalemia increases arrhythmia risk.
- Monitor blood glucose; isoprenaline may cause hyperglycemia.
Indications & Cautions
- Uses: Symptomatic bradycardia or complete heart block unresponsive to atropine (bridge to pacing); bradycardia-dependent torsades de pointes with acquired long QT.
- Congenital Long QT: Contraindicated; adrenergic stimulation can trigger torsades.
- Ischemic Heart Disease: Avoid or use with extreme caution because of increased oxygen demand.
- Existing Tachyarrhythmias or Digitalis Toxicity: Contraindicated.
Arrhythmia & Ischemia Response Protocol
Isoprenaline is not a vesicant; its principal hazards are tachyarrhythmias, myocardial ischemia, and hypotension. Its short half-life means effects fade within minutes of stopping.
Expected Response
- Heart rate at prescribed target
- Blood pressure and perfusion maintained
- No chest pain or new ST changes
- No new ventricular ectopy
Tachyarrhythmia, Chest Pain, or Hypotension:
- STOP or reduce infusion immediately.
- Notify clinician promptly; obtain a 12-lead ECG.
- Prepare for pacing if bradycardia recurs after stopping.
- Check potassium and magnesium.
- Document event in patient clinical record.
Isoprenaline Infusion Rate Chart (20 mcg/mL)
Shows the pump rate (mL/hr) for each dose in mcg/min, with the equivalent weight-based dose in mcg/kg/min for reference.
| Dose (mcg/min) |
Pump Rate (mL/hr) |
Equivalent Dose (mcg/kg/min) | ||
|---|---|---|---|---|
| 50 kg | 70 kg | 90 kg | ||
| 0.5 | 1.5 | 0.010 | 0.007 | 0.006 |
| 1 | 3 | 0.020 | 0.014 | 0.011 |
| 1.5 | 4.5 | 0.030 | 0.021 | 0.017 |
| 2 | 6 | 0.040 | 0.029 | 0.022 |
| 2.5 | 7.5 | 0.050 | 0.036 | 0.028 |
| 3 | 9 | 0.060 | 0.043 | 0.033 |
| 4 | 12 | 0.080 | 0.057 | 0.044 |
| 5 | 15 | 0.100 | 0.071 | 0.056 |
| 6 | 18 | 0.120 | 0.086 | 0.067 |
| 8 | 24 | 0.160 | 0.114 | 0.089 |
| 10 | 30 | 0.200 | 0.143 | 0.111 |
Infusion Conversion (Solution Concentration 20 mcg/mL)
Standard equations for a 20 mcg/mL solution (1 mg in 50 mL):
Rate (mL/hr) = [ Dose (mcg/min) × 60 ] / 20
Shortcut: Rate = Dose × 3
Dose (mcg/min) = [ Rate (mL/hour) × Concentration (20 mcg/mL) ] / 60
Shortcut: Dose = Rate ÷ 3
'Shortcut' example: 2 mcg/min → 2 × 3 = 6 mL/hr.